Novavax (NVAX) Interest Coverage Ratio (2010 - 2026)
Novavax (NVAX) posted quarterly Interest Coverage Ratio of 2.45 for Q1 2026, down 102.72% year-over-year from 90.08 in Q1 2025, and down 150.55% quarter-over-quarter from 4.85 in Q4 2025.
Novavax (NVAX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Novavax's Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 2.45 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 102.72% year-over-year to 2.45; the TTM figure through Mar 2026 stood at 3.82 (down 166.07% YoY), while the FY2025 annual figure was 0.44, up 301.37% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 2.45, down from 4.85 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 90.08 in Q1 2025, with the low at 77.47 in Q2 2022.
- The 5-year median for Interest Coverage Ratio is 2.45 (2026), against an average of 8.72.
- The sharpest annual moves came in 2023 and 2025: Interest Coverage Ratio slumped 251.44% in 2023, then soared 355.68% in 2025.
- Novavax's Interest Coverage Ratio stood at 53.01 in 2022, then jumped by 96.13% to 2.05 in 2023, then retreated by 11.99% to 2.3 in 2024, then soared by 311.26% to 4.85 in 2025, then tumbled by 150.55% to 2.45 in 2026.
- Business Quant data shows NVAX's Interest Coverage Ratio at 2.45 in Q1 2026, 4.85 in Q4 2025, and 23.27 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | -6.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.70 |
| Mar 31, 2026 | -2.45 |
| Dec 31, 2025 | 4.85 |
| Sep 30, 2025 | -23.27 |
| Jun 30, 2025 | 18.32 |
| Mar 31, 2025 | 90.08 |
| Dec 31, 2024 | -2.30 |
| Sep 30, 2024 | -31.64 |
| Jun 30, 2024 | 38.86 |
| Mar 31, 2024 | -35.23 |
| Dec 31, 2023 | -2.05 |
| Sep 30, 2023 | -43.94 |
| Jun 30, 2023 | 17.75 |
| Mar 31, 2023 | -47.63 |
| Dec 31, 2022 | -53.01 |
| Sep 30, 2022 | -30.51 |
| Jun 30, 2022 | -77.47 |
| Mar 31, 2022 | 31.45 |
| Dec 31, 2021 | -160.56 |
| Sep 30, 2021 | -59.27 |